Palliative care for Parkinson's disease: has the time come?

Current Neurology and Neuroscience Reports
Janis M Miyasaki, Benzi Kluger

Abstract

Although Parkinson's disease (PD) is traditionally viewed as a movement disorder which affects quality of life, recent literature has revealed an increased mortality, a high burden of difficult-to-manage non-motor symptoms (e.g., pain, fatigue), high caregiver distress, and a high utilization of medical services especially in the last year of life. Current medical systems have yet to adequately respond to this mounting evidence through the adoption of palliative care practices and through the provision of palliative care services to both PD patients and to affected families. This holistic, interdisciplinary approach to practice would enhance care delivery, identify and address unmet needs, and avoid interventions and hospitalizations especially in the last months of life. As we approach an era of increased life expectancy, increasing comorbidities among patients, and escalating healthcare costs, physicians must be proactive in focusing on quality of life, reducing medical interventions, and respecting patient autonomy.

References

Nov 20, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Mariese A HelyRobert Trafficante
Apr 15, 2006·Palliative Medicine·Peter L HudsonLinda J Kristjanson
Jun 26, 2007·Brain : a Journal of Neurology·P A KempsterA J Lees
Aug 8, 2007·Neurology·Elizabeth R GoyLinda Ganzini
Oct 26, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Amy P AbernethyMaragatha Kuchibhatla
Mar 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Mariese A HelyJohn G L Morris
Jul 25, 2009·Age and Ageing·Kalyani SnellRichard Walker
Oct 19, 2010·Palliative Medicine·Dorry McLaughlinHelen Chambers
Feb 2, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Oliver H H GerlachWim E J Weber
Jan 4, 2012·Archives of Neurology·Allison W WillisBrad A Racette
Mar 1, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Man AuyeungE Yeung
Aug 8, 2012·Parkinsonism & Related Disorders·Janis M MiyasakiJ Hui
Jun 27, 2013·Health and Quality of Life Outcomes·Michele PetersRay Fitzpatrick
Jul 10, 2013·Parkinsonism & Related Disorders·Anhar HassanUNKNOWN NPF-QII Investigators
Nov 16, 2013·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Seockhoon ChungRonald D Chervin
Dec 18, 2013·Medical Education·Robert HorowitzTimothy Quill
Jan 1, 2014·Journal of Clinical Nursing·Patrice FedelLee Jeske
Mar 20, 2014·BMJ Supportive & Palliative Care·Richard W WalkerWilliam K Gray
May 31, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Michal LubomskiStephen Tisch
Jun 24, 2014·Dysphagia·Danielle CarneiroOtávio Gomes Lins
Jul 6, 2014·Neurology·Isabel BoersmaBenzi Kluger
Aug 1, 2014·Qualitative Health Research·Laura Foran Lewis

❮ Previous
Next ❯

Citations

May 19, 2017·Journal of Palliative Medicine·Isabel BoersmaBenzi Kluger
Nov 28, 2017·BMC Palliative Care·Herma LennaertsBastiaan R Bloem
Feb 14, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Raquel Bouça-MachadoJoaquim J Ferreira
Sep 12, 2018·Journal of Palliative Medicine·Maya KatzSteve Z Pantilat
Sep 20, 2018·Journal of Palliative Care·Radka BužgováLubica Juríčková
Aug 9, 2016·Continuum : Lifelong Learning in Neurology·Janis M Miyasaki
Oct 13, 2018·Journal of Palliative Medicine·Danny EstupinanRobert P Shannon
Dec 21, 2018·Expert Review of Neurotherapeutics·Danique L M RadderBastiaan R Bloem
Jun 15, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Leandro ProvincialiEugenio Pucci
Feb 22, 2018·Current Treatment Options in Neurology·Christina L Vaughan, Benzi M Kluger
Jun 2, 2020·Expert Review of Neurotherapeutics·Sarah C LidstoneAnthony E Lang
Jul 6, 2020·Fortschritte der Neurologie-Psychiatrie·Gerhard Ransmayr
Sep 8, 2016·Neurodegenerative Disease Management·Seyed-Mohammad Fereshtehnejad
May 16, 2020·Journal of Medical Ethics·Frederic Gilbert, Mathilde Lancelot
Mar 7, 2019·Movement Disorders Clinical Practice·Benzi M KlugerDavid B Bekelman
Mar 28, 2019·Frontiers in Neurology·Jenny T van der SteenRaymond T C M Koopmans
Feb 9, 2017·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Anita M DayalTeneille E Gofton
Jan 14, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Maya Katz
Feb 15, 2021·International Journal of Nursing Studies·Marianne Sofronas, David Kenneth Wright
Apr 2, 2021·Journal of Neurology, Neurosurgery, and Psychiatry·Umer AkbarBenzi Kluger
Aug 26, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Janis M MiyasakiUNKNOWN Task Force on Palliative Care of the International Parkinson and Movement Disorder Society

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurología : publicación oficial de la Sociedad Española de Neurología
E Cubomiembros del grupo ELEP
Journal of the Neurological Sciences
Diego Santos-García, Raúl de la Fuente-Fernández
Movement Disorders : Official Journal of the Movement Disorder Society
Pablo Martínez-Martín
Pneumonologia i alergologia polska
Aleksandra ModlińskaMonika Lichodziejewska-Niemierko
© 2021 Meta ULC. All rights reserved